Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis [Phase 2, Phase 3]
Phase 2/3 trials assess the safety and efficacy of sublingual immunotherapy tablets for grass pollen–induced allergic rhinoconjunctivitis; r…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of a 300 IR grass pollen sublingual immunotherapy tablet in adults with grass pollen-induce…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis [Phase 2, Phase 3]
Phase 2 and Phase 3 trial updates on sublingual immunotherapy for house dust mite–related allergic rhinitis; results have been posted.
-
CLINICAL_TRIALS safety_alert · 2016-05-16Clinical Trial Update: Post Marketing Surveillance for Contac Bien Z in Japan
Post-marketing safety surveillance for Contac Bien Z in Japan has been completed. The surveillance evaluated safety in patients with allergi…
-
FDA approval · 2016-05-12FDA Approved: CARBINOXAMINE MALEATE EXTENDED-RELEASE ORAL SUSPENSION — Supplemental Application (Neos Therapeutics, LP)
FDA approved a supplemental application to authorize a new extended-release oral suspension formulation of carbinoxamine maleate by Neos The…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: Comparison of Skin Prick Testing Results of Local and Imported Pollen Allergen Extracts and Specific IgE
This completed trial from Mahidol University compared skin prick test results for local versus imported pollen allergen extracts and assesse…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Evaluation of the Animated Cartoon-aided Teaching of Intranasal Corticosteroid Allergic Rhinitis [NA]
Completed clinical trial update evaluating cartoon-aided teaching for intranasal corticosteroid use in allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Pangramin SLIT HDM-mix for house dust mite-induced allergic rhinitis. Results were poste…
-
FDA approval · 2016-04-29FDA Approved: BUDESONIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for budesonide. The action reflects changes to the product's labeling…
-
CLINICAL_TRIALS research · 2016-04-22Clinical Trial Update: Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis. [NA]
A clinical trial is evaluating the effectiveness of Qufeng Shengshi Fang for allergic rhinitis (perennial). The trial status is UNKNOWN.
-
FDA approval · 2016-04-19FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Montelukast Sodium from Unichem Pharmaceuticals (USA), Inc., under the ANDA.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Allergic Rhinitis, Immunotherapy and Vitamin d [Phase 2, Phase 3]
A clinical trial update on allergic rhinitis exploring immunotherapy with vitamin D in Phase 2 and Phase 3 trials, sponsored by Hospital Gen…
-
FDA approval · 2016-04-05FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application to add grape and bubblegum chewable forms of Claritin (loratadine) from Bayer HealthCare LLC, ex…
-
FDA approval · 2016-03-23FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra Hives 24HR (fexofenadine hydrochloride) from Chattem, Inc., supporting the product's use…
-
FDA approval · 2016-03-22FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Nasacort Allergy 24HR (triamcinolone acetonide nasal spray) from Chattem, Inc., updating its lab…
-
FDA approval · 2016-03-09FDA Approved: ZYRTEC-D — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for ZYRTEC-D, a combination of cetirizine hydrochloride and pseudoephedrine hydrochloride, submi…
-
FDA approval · 2016-03-08FDA Approved: BUDESONIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a generic budesonide product under an Original Application (ANDA 204548) for Teva Pharmaceuticals USA, Inc. This marks the appr…
-
FDA approval · 2016-03-01FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for Montelukast Sodium (montelukast) under an ANDA.
-
FDA approval · 2016-02-29FDA Approved: QNASL — Supplemental Application (Teva Respiratory, LLC)
FDA approved a supplemental application for QNASL (beclomethasone dipropionate) from Teva Respiratory, LLC. The approval updates the product…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays [Phase 4]
Phase 4 trial update on patient preference comparing fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis condition…
-
FDA approval · 2016-02-29FDA Approved: FLUTICASONE PROPIONATE — Original Application (Selder, S.A. de C.V.)
FDA approved the Original Application for a generic nasal spray containing fluticasone propionate (Allergy Relief Nasal) from Selder, S.A. d…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis [NA]
A clinical trial studied daily use of Lipikar Balm AP from birth in infants at high risk of developing atopic dermatitis. The trial was term…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Titrated Quantitative Conjunctival Provocation Test (tqCPT) [NA]
Clinical trial update regarding the titrated quantitative conjunctival provocation test (tqCPT) for allergic rhinitis; the study status is c…
-
FDA approval · 2016-02-12FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) submitted by Bayer HealthCare LLC.
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Safety of Lymph Node Injection for Allergen Immunotherapy [Phase 1]
Phase 1 trial assessing the safety of lymph node injections for allergen immunotherapy in allergic rhinitis.